Repositioning of Ureteropelvic Junction in Robot-assisted Laparoscopic Pyeloplasty.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
03 Nov 2023
Historique:
received: 28 08 2023
accepted: 16 10 2023
pubmed: 6 11 2023
medline: 6 11 2023
entrez: 3 11 2023
Statut: aheadofprint

Résumé

To describe the technique of ureteropelvic junction (UPJ) repositioning in robot-assisted dismembered pyeloplasty as a modified approach during which the UPJ is brought to a new location to facilitate the anastomosis. Retrospective review of pediatric and adult cases of robot-assisted laparoscopic pyeloplasty performed between the years 2016 and 2022. In a select group of patients, repositioning of the UPJ was performed. Demographic data, surgical and post-surgical outcomes were compared to a group that underwent classical Anderson-Hynes (AH) dismembered pyeloplasty. Overall, 70 patients underwent robot-assisted laparoscopic dismembered pyeloplasty and were included in the study, with 15 in the repositioning group and 55 in the AH group. The median age of patients included was 26 months (interquartile range (IQR) 7-203). Median operative time was 140 minutes (IQR 129-192) and 170 minutes (IQR 135-207) for the repositioning and AH group, respectively. The indications for UPJ repositioning were high UPJ insertion (n = 8), crossing vessel (n = 5), and renal malformations (n = 2). Clinical significance was shown in the Society of Fetal Urology classification and split renal function postoperatively, respectively (P <.001; P <.01). Postoperatively, both groups showed improvement in anterior posterior diameter (APD) and diuretic T Repositioning of the UPJ is optional in cases when the obstructed UPJ is in a suboptimal anatomical position.

Identifiants

pubmed: 37923088
pii: S0090-4295(23)00947-0
doi: 10.1016/j.urology.2023.10.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Leon Chertin (L)

Department of Urology, Shamir Medical Center, Zerifin, Israel; Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: lchertin1@gmail.com.

Avigal Lask (A)

Department of Urology, Shamir Medical Center, Zerifin, Israel; Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Andrew Shumaker (A)

Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Urology, Meir Medical Center, Kfar Saba, Israel.

Amnon Zisman (A)

Department of Urology, Shamir Medical Center, Zerifin, Israel; Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amos Neheman (A)

Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Urology, Meir Medical Center, Kfar Saba, Israel.

Classifications MeSH